Prions amplify through degradation of the VPS10P sorting receptor sortilin

PLoS Pathog. 2017 Jun 30;13(6):e1006470. doi: 10.1371/journal.ppat.1006470. eCollection 2017 Jun.

Abstract

Prion diseases are a group of fatal neurodegenerative disorders caused by prions, which consist mainly of the abnormally folded isoform of prion protein, PrPSc. A pivotal pathogenic event in prion disease is progressive accumulation of prions, or PrPSc, in brains through constitutive conformational conversion of the cellular prion protein, PrPC, into PrPSc. However, the cellular mechanism by which PrPSc is progressively accumulated in prion-infected neurons remains unknown. Here, we show that PrPSc is progressively accumulated in prion-infected cells through degradation of the VPS10P sorting receptor sortilin. We first show that sortilin interacts with PrPC and PrPSc and sorts them to lysosomes for degradation. Consistently, sortilin-knockdown increased PrPSc accumulation in prion-infected cells. In contrast, overexpression of sortilin reduced PrPSc accumulation in prion-infected cells. These results indicate that sortilin negatively regulates PrPSc accumulation in prion-infected cells. The negative role of sortilin in PrPSc accumulation was further confirmed in sortilin-knockout mice infected with prions. The infected mice had accelerated prion disease with early accumulation of PrPSc in their brains. Interestingly, sortilin was reduced in prion-infected cells and mouse brains. Treatment of prion-infected cells with lysosomal inhibitors, but not proteasomal inhibitors, increased the levels of sortilin. Moreover, sortilin was reduced following PrPSc becoming detectable in cells after infection with prions. These results indicate that PrPSc accumulation stimulates sortilin degradation in lysosomes. Taken together, these results show that PrPSc accumulation of itself could impair the sortilin-mediated sorting of PrPC and PrPSc to lysosomes for degradation by stimulating lysosomal degradation of sortilin, eventually leading to progressive accumulation of PrPSc in prion-infected cells.

MeSH terms

  • Adaptor Proteins, Vesicular Transport / metabolism*
  • Animals
  • Lysosomes / metabolism
  • Mice
  • Neurons / metabolism
  • PrPC Proteins / metabolism*
  • PrPSc Proteins / metabolism*
  • Prion Diseases / metabolism
  • Prions / metabolism*
  • Protein Transport / physiology

Substances

  • Adaptor Proteins, Vesicular Transport
  • PrPC Proteins
  • PrPSc Proteins
  • Prions
  • sortilin

Grants and funding

This work was supported by the following: Pilot Research Support Program in Tokushima University (http://www.tokushima-u.ac.jp/) received by KU; Naito Foundation (https://www.naito-f.or.jp/jp/index.php) received by KU; JSPS KAKENHI grant (grant No. 26460557, https://www.jsps.go.jp/english/e-grants/) received by KU; MEXT KAKENHI grant (grant No, 17H05702, https://www.jsps.go.jp/english/e-grants/) received by KU; JSPS KAKENHI grant (grant No. 26293212, https://www.jsps.go.jp/english/e-grants/) received by SS; MEXT KAKENHI grant (grant No, 15H01560 and 17H05701, https://www.jsps.go.jp/english/e-grants/) received by SS; and Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development (AMED, http://www.amed.go.jp/) received by SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.